Viridian Therapeutics, Inc. (VRDN)
14.95
-0.43
(-2.80%)
USD |
NASDAQ |
Apr 10, 15:59
14.66
-0.29
(-1.94%)
After-Hours: 20:00
Viridian Therapeutics Profit Margin (Quarterly) : -77.26K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -154.4% |
| Boston Scientific Corp. | 12.68% |
| Plus Therapeutics, Inc. | -417.9% |
| Nutriband, Inc. | -1.12K% |
| Immunovant, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -53.74% |
| Return on Assets | -46.82% |
| Return on Invested Capital | -51.30% |
| Gross Profit Margin (Quarterly) | -142.4% |
| Operating Margin (Quarterly) | -92.99K% |
| Return on Net Operating Assets | -1.86K% |